Division Of Renal Kidney Medicine At Brigham News Today : Breaking News, Live Updates & Top Stories | Vimarsana

SGLT2 Inhibitors Reduce Kidney Stone Risk in Type 2 Diabetes

Patients with type 2 diabetes treated with SGLT2 inhibitors vs other common diabetes drugs show up to a 31% reduced risk of kidney stone development.

United statesJulie paikDivision of pharmacoepidemiologyDivision of renal kidney medicine at brighamMedscape medicalUrinary citrateDiabetes mellitus type 2Iabetes mellitus type iiType 2 diabetesYpe 2 dmKidney stonesRenal calculusRenal calculiSglt2 inhibitorsOdium glucose transporter 2 inhibitorsOdium glucose co transporter 2 inhibitors

Kidney stones: Type 2 diabetes medication may help lower risk

A type of medication used to treat type 2 diabetes could help lower the risk of developing kidney stones, a new study suggests.

New jerseyUnited statesJulie paikJennifer chengDivision of pharmacoepidemiologyDivision of renal kidney medicine at brighamHackensack meridian jersey shore university medical centerMedical news

Kidney stone risk is lowered by a class of diabetes medications: Study

The study shows that sodium-glucose contratransporter 2 (SGLT2) inhibitors can reduce the risk of acquiring kidney stones. | Health

United statesJulie paikDivision of renal kidney medicine at brighamDivision of pharmacoepidemiologyMass general brighamMassachusetts general hospitalKidney stonesKidney stones symptomsKidney stones treatmentKidney stones causesKidney stones preventionKidney stones signs

Kidney stone risk is lowered by a class of diabetes medications: Study

Kidney stone risk is lowered by a class of diabetes medications: Study
bignewsnetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bignewsnetwork.com Daily Mail and Mail on Sunday newspapers.

United statesLos angelesJulie paikDivision of renal kidney medicine at brighamDivision of pharmacoepidemiologyMass general brighamMassachusetts general hospital

Diabetes Drug Can Cut Risk of Kidney Stones

Discover the potential of SGLT2 inhibitors- a class of diabetes drugs, in mitigating kidney stones risk in diabetic patients.

United statesJulie paikDivision of pharmacoepidemiologyDivision of renal kidney medicine at brighamMass general brighamGlucose cotransporterNephrolithiasis riskPatients with typePatients ratesMassachusetts general hospitalDiabetes drugSglt2 inhibitorsKidney stonesType 2 diabetesChronic kidney disease